SEC Settles Insider Trading Suit Against Biotech Investor
The U.S. Securities and Exchange Commission announced on Tuesday that a Texas-based investor will pay over $240,000 to settle the agency's claims he improperly traded stocks on insider information by buying...To view the full article, register now.
Already a subscriber? Click here to view full article